Form 4: Ardent Health Partners Director Acquires and Disposes of Shares
SEC Form 4 Filing
Robert Thomas Webb, a director of Ardent Health Partners, reports acquiring and disposing of common stock on July 18, 2024.
Summary
- On July 18, 2024, Robert Thomas Webb, a director of Ardent Health Partners, engaged in transactions involving the company's common stock.
- Webb acquired 11,562 shares of common stock at $0.
- Webb disposed of shares, resulting in a total of 20,275 shares beneficially owned following the reported transactions.
- The acquisition involved restricted stock units that vest on the first anniversary of March 31, 2024, contingent upon continued service with the issuer.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting insider trading activity, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects insider activity, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date upon which the restricted stock units vest in full on the first anniversary. |
| 07/18/2024 | Date of the stock acquisition and disposal transaction. |
| 07/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.